Stockwinners Market Radar for April 29, 2019 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:02 EDT Cummins to review its pickup truck emissions certification after EPA discussions - Cummins announced that it is formally reviewing its emissions certification and compliance process for its pickup truck applications. Following conversations with the U.S. EPA and CARB regarding certification for the engines in the 2019 RAM 2500 and 3500 trucks, the company made the decision to review its certification process and compliance with emissions standards. Cummins has voluntarily disclosed the review to regulators and other agencies.

18:54 EDT Fly Intel: After Hours Movers - UP AFTER EARNINGS: Impinj (PI) up 25.4%... Sanmina (SANM) up 10.4%... CURO Group Holding (CURO) up 10.3%... Woodward (WWD) up 7.0%... Intevac (IVAC) up 4.8%... Medpace (MEDP) up 4.7%... Gaia (GAIA) up 4.6%... Tenet Healthcare (THC) up 3.4%... Molina Healthcare (MOH) up 3.3%... Continental Resources (CLR) up 3.1%... John Bean Tech (JBT) up 3.1%... AK Steel (AKS) up 2.9%... Yum China (YUMC) up 2.8%... Varonis (VRNS) up 2.6%... Murphy USA (MUSA) up 2.1%... TriNet Group (TNET) up 2.0%. ALSO HIGHER: G1 Therapeutics (GTHX) up 21.6% after announcing plans to request pre-NDA meeting for Trilaciclib... Neophotonics (NPTN) up 5.4% after being initiated with Buy at MKM Partners. DOWN AFTER EARNINGS: Cognex (CGNX) down 14.3%... Trex Company (TREX) down 12.5%... Harmonic (HLIT) down 10.3%... Intricon (IIN) down 10.0%... Greenhill (GHL) down 7.5%... Alphabet (GOOGL) down 7.2%... Texas Roadhouse (TXRH) down 7.1%... MKS Instruments (MKSI) down 7.0%... Western Digital (WDC) down 5.1%... Chegg (CHGG) down 5.1%... Neurocrine Bio (NBIX) down 4.9%... Ethan Allen (ETH) down 3.7%... PotlatchDeltic (PCH) down 2.7%... MGM Resorts (MGM) down 2.3%... Leggett & Platt (LEG) down 1.6%. ALSO LOWER: Mustang Bio (MBIO) down 10.5% after equity offering. Movers as of 18:30ET.

18:05 EDT Marriott launches Homes & Villas rentals in over 100 markets - Marriott announced Homes & Villas by Marriott International, a home rental initiative offering 2,000 premium and luxury homes located in over 100 destinations throughout the United States, Europe, the Caribbean and Latin America.

17:39 EDT FAANG names fall after Alphabet reports quarterly results - Shares of FAANG stocks or Facebook (FB), Amazon (AMZN), Apple (AAPL), Netflix (NFLX) and Google (GOOG) are all trading lower following Alphabet's Q1 earnings report. The company missed analyst expectations for revenue, sending shares down approximately 7% or 90 dollars to $1,198 per share. Shares of Facebook (FB), Amazon (AMZN), Apple(AAPL), Netflix (NFLX) are all down fractionally in after-hours trading, while Shares of Google are down 7%.

17:27 EDT Western Digital says on track for 10%-15% flash memory bit output cut in FY19 - Says flash inventory levels in March quarter were "essentially unchanged" despite seasonal softness. Says stopped production at Kuala Lampur facility and consolidated manufacturing operations from Thailand to Philippines. Says flash pricing conditions remain challenging but expect the rate of price decline to moderate as FY19 progresses on "slowing rate of industry supply growth, elasticity driving demand, and seasonal strength in second half of 2019."

17:24 EDT Boeing awarded $171.89M Army contract for Apache helicopter fleet support - Boeing has been awarded a $171.89M hybrid contract for performance based logistics service in support of the AH-64E Apache attack helicopter fleet. One bid was solicited with one bid received. Work will be performed in Mesa, Arizona, with an estimated completion date of April 30, 2020. FY18 working capital funds in the amount of $63.78M were obligated at the time of the award. U.S. Army Contracting Command is the contracting activity.

17:20 EDT Raytheon awarded $663.06M Army contract for Troposcatter Transmission System - Raytheon was awarded a $663.06M firm-fixed-price contract for Troposcatter Transmission System, spares, repairs, warranty, system engineering, field support, training and sustainment. Bids were solicited via the internet with two received. Work locations and funding will be determined with each order, with an estimated completion date of April 25, 2029. U.S. Army Contracting Command is the contracting activity.

17:18 EDT Lockheed Martin awarded $1.15B Navy contract for F-35 support - Lockheed Martin has been awarded a $1.15B cost-plus-incentive-fee, cost-plus-fixed-fee, firm-fixed-price, cost share contract for sustainment services in support of the F-35 Lightning II aircraft for the Air Force, Navy, non-U. S. Department of Defense participants and foreign military sales, or FMS, customers. Services to be provided include ground maintenance activities, action request resolution, depot activation activities, automatic logistics information system operation and maintenance; reliability, maintainability and health management implementation and support; supply chain management; and activities to provide and support pilot and maintainer initial training. Work is expected to be completed in December 2022. FY19 operations and maintenance, non-U.S. DoD participant and FMS funds in the amount of $1.14B will be obligated at time of award, $811.25M which will expire at the end of the current fiscal year. This contract was not competitively procured pursuant to Federal Acquisition Regulation 6.302-1. This contract combines purchases for the Air Force, Navy, non-U.S. DoD participants and FMS customers. The Naval Air Systems Command is the contracting activity.

17:16 EDT Intevac says HDD business is stable - Says focused on enhancing the value proposition of vertex. Says vertex continues to be a significant revenue opportunity. Says anticipates increasing opportunities for matrix system.

17:12 EDT Boeing awarded $5.7B Air Force contract for KC-46 PC2 - Boeing has been awarded a $5.7B indefinite-delivery/indefinite-quantity contract for KC-46 Pegasus combat capability, or PC2. This contract provides for a broad range of post-production related non-recurring and recurring requirements centered on user-directed and Federal Aviation Administration-mandated KC-46 air vehicle needs. Work will be performed in Seattle, Washington, and is expected to be complete by April 28, 2029. This award is the result of a sole-source acquisition. FY18 research, development, test and evaluation funds in the amount of $9.12M are being obligated on the first delivery order at the time of award. Air Force Life Cycle Management Center is the contracting activity.

17:11 EDT Alphabet says YouTube paid click growth has slowed - Says committed to become most customer-centric cloud provider for enterprise customers. Says YouTube paid click growth has slowed.

17:00 EDT Highbridge Capital reports 5.29% passive stake in Organogenesis - Highbridge Capital disclosed a 5.29% stake in Organogenesis, which represents over 5.14M shares. The filing does not allow for activism.

16:54 EDT Alphabet says Stadia's reception from gamers 'incredible' - Says reception from gamers on Stadia has been "incredible." Says YouTube's top priority is responsibility. Says Q1 showed that YouTube was "go-to" for viewing Super Bowl ads.

16:50 EDT Alphabet 'pleased' with progress of Home Hub, Home Mini - Says "pleased" with progress of Home Hub and Home Mini hardware. Says still expects 2019 CapEx to exceed 2018 numbers. Says AI "deeply embedded" in company's products.

16:46 EDT Google says Q1 hardware results reflect lower y/y sales of Pixel - Sees continued headwinds to revenues and net income. Says hardware results reflect lower year-over-year sales of Pixel. Says remains confident of "sizable" opportunity to improve advertiser and user experience. Says "pleased" with momentum of Google Cloud platform. Comments taken from Q1 earnings conference call.

16:46 EDT Marathon Petroleum to extend binding open season by one week - Capline Pipeline announced that it will extend its binding open season by one week. In response to feedback from potential shippers, Capline has made minor revisions to its open season documents. The binding open season will be extended to May 7, to allow potential shippers adequate time to review these revisions, and to provide additional time to finalize commitments to Capline and connecting infrastructure.

16:41 EDT Alliance Data announces share exchange act with ValueAct - Alliance Data announced its entry into an exchange agreement with ValueAct Holdings, L.P. Pursuant to the terms of the agreement, ValueAct Capital Master Fund, L.P., Alliance Data's largest shareholder, exchanged 1.5M of its 5,207,646 shares of Alliance Data common stock for 150,000 shares of Alliance Data's newly-designated class of Series A Non-Voting Convertible Preferred Stock.

16:38 EDT Regal Beloit raises quarterly dividend 7% to 30c per share - Payable on July 12 to shareholders of record at the close of business on June 28.

16:37 EDT Simpson Manufacturing expect Q2 steel price to remain flat or slightly decrease - Subject to changing economic conditions, future events and circumstances the company provided the following guidance. The Company currently believes the market price for steel could be flat or decrease slightly during the Q2. The Company estimates that its FY19 gross profit margin will be between approximately 44.5%-45.5%. The Company estimates that its 2019 full-year operating expenses, as a percentage of net sales, will be between approximately 27.5% and 28.5%. The Company estimates that its FY19 effective tax rate will be between approximately 25%-27%, including both federal and state income tax rates. The ultimate impact of the Tax Cuts and Jobs Act signed into law in 2017 and the Company's 2019 effective tax rate may differ materially from the Company's estimates due to changes in the interpretations and assumptions made by the Company as well as additional regulatory guidance that may be issued and actions the Company may take as a result of the Tax Cuts and Jobs Act, such as cash repatriation to the United States. The Company will continue to assess the expected impact of the new tax law and provide additional disclosures at appropriate times.

16:34 EDT Shenandoah appoints Chase Stobbe CAO, Elaine Cheng CIO - Shenandoah announced that Chase Stobbe has joined the company as VP and chief accounting officer, or CAO, and Elaine Cheng has joined as VP and chief information officer, or CIO. Stobbe will be responsible for the leadership of Shentel's accounting function. Previously, he was a senior manager in the audit practice of KPMG, LLP where he focused on serving public telecommunications companies over the last twelve years. Cheng will be responsible for the leadership of Shentel's information technology function. For the past eight years, she has served as CIO and managing director, global strategic design, for CFA Institute in Charlottesville, Virginia.

16:33 EDT Yum China CEO says 'we are pleased to report a very strong start to 2019' - "We are pleased to report a very strong start to 2019 as we delivered a 9% increase in system sales in constant currency in the first quarter, our tenth consecutive quarter of system sales growth since the spin-off," said Joey Wat, CEO of Yum China. "This resilient growth was driven by another robust quarter at KFC, which successfully lapped three strong first quarters between 2016 and 2018, and a very encouraging quarter at Pizza Hut. Pizza Hut delivered positive same-store sales growth and a significant improvement in profitability in the first quarter, while continuing to make strategic investments in value offerings and multiple other initiatives to drive the ongoing revitalization of the brand." "During the first quarter, we opened 237 stores, led by an acceleration of KFC openings, as we continued to identify attractive opportunities to expand our presence in underserved markets. We also continued to invest in enhancing our digital and delivery capabilities, which are vital drivers of same-store sales growth across our portfolio of brands," added Wat. "We achieved a 9% increase in adjusted operating profit during the first quarter, excluding special items and F/X, as sales leverage at KFC and a notable improvement in Pizza Hut's margin offset cost inflation and increased promotions," said Jacky Lo, CFO of Yum China. "This enabled us to continue to generate significant cash flow and fund shareholder returns. During the quarter, we returned $111 million to shareholders in the form of share repurchases and cash dividends. Looking ahead, based on our current pipeline, we are confident that our 2019 gross new openings will exceed the top end of our original target of 600 to 650 stores. While we expect poultry inflation to weigh on margins for the rest of the year, and Pizza Hut's revitalization program is still ongoing, the long-term outlook for growth remains positive and we remain committed to generating significant value for our shareholders."

16:32 EDT Yum China reports Q1 restaurant margin was 18.5% vs. 17.9% a year ago

16:31 EDT Yum China reports Q1 total system sales up 9% y/y - Total system sales grew 9% year over year, with growth of 11% at KFC and 3% at Pizza Hut, excluding F/X.

16:30 EDT G1 Therapeutics trading resumes

16:25 EDT Standex sees Q4 'stronger' than Q3 but below last year's Q4 - CEO David Dunbar says: "While we continue to have challenges in some of our end markets, the contributions from our growth laneways and new product offerings with attractive margin profiles are increasing. Additionally, we are implementing several initiatives throughout the organization to strengthen our operations and performance. We expect our Q4 will be sequentially stronger than Q3, but below last year's Q4. Looking ahead to FY20, we expect that performance will improve as we benefit from scheduled platform rollouts in the automotive OEM market, continued strength in the Engineering and Hydraulics segments and segment-level productivity programs we are currently implementing."

16:22 EDT Trinseo names David Stasse as new CFO - Trinseo has named David Stasse as Executive Vice President and CFO effective July 1. Stasse is currently the company's Vice President or Treasury and Investor Relations.

16:21 EDT MGM Resorts reports Q1 MGM China net revenue up 23% to $734M - MGM China: Net revenues increased 23% to $734M including $301M from a full quarter of operations at MGM Cotai compared to $85M in the prior year quarter as the property opened on February 13, 2018; and Adjusted Property EBITDA of $191M, a 26% increase compared to the prior year quarter, reflecting a full quarter of operations and the addition of 25 new-to-market tables on January 1, 2019 at MGM Cotai. "MGM 2020 is our key focus. We have developed a comprehensive roadmap and we expect to deliver on our 2020 plans and operating model transformation. This re-investment into our business is expected to result in Adjusted EBITDA uplift of $300 million in 2021, compared to when we launched the plan, with phase 1 of $200 million in 2020 and phase 2 of $100 million in 2021. We are making good progress," said Corey Sanders, CFO of MGM Resorts. "We also continue to be focused on fortifying our balance sheet. Earlier this month, we raised $1 billion of senior notes at very attractive rates and used the proceeds to address our near-term maturities. We remain confident in our goal to get our consolidated net leverage to 3-4x by year end 2020."

16:18 EDT MGM Resorts CEO says Q1 'came in slightly better than our expectations' - "The first quarter came in slightly better than our expectations with consolidated net revenues up by 13% and Adjusted EBITDA up 5%," said Jim Murren, Chairman and CEO of MGM Resorts International. "Our Las Vegas resorts experienced broad and diversified customer demand. Our non-gaming revenues grew by 4%. We had healthy gaming business outside of baccarat, but previously flagged factors such as a very strong baccarat business in the prior year period and a low win rate in the current period led to flat revenues and a 10% decrease in Adjusted Property EBITDA year over year. Our Regional properties performed exceptionally well with 24% growth in Adjusted Property EBITDA, or 9% on a same store basis. MGM Grand Detroit, MGM National Harbor and our Mississippi properties had strong quarters. MGM Cotai continued to ramp and contributed to the 26% growth in Adjusted Property EBITDA at MGM China. During the quarter, we were very pleased to receive the extension to our Macau sub-concession to June 2022. We remain deeply committed to Macau's continued evolution into an international leisure and tourism destination." Murren continued, "We remain focused on achieving our 2020 targets of $3.6 billion to $3.9 billion in consolidated Adjusted EBITDA and significant growth in free cash flow. Our strategy to achieve these goals includes the continued ramping up of MGM Cotai, Park MGM and MGM Springfield, and the implementation of the MGM 2020 Plan. MGM 2020 is a company-wide initiative aimed at leveraging a more centralized organization to maximize profitability and lay the groundwork for the Company's digital transformation to drive revenue growth. We are creating a streamlined, nimble organization that empowers leaders to make faster decisions. We are excited about our targeted growth opportunities in Japan, sports betting and interactive initiatives. At the same time, we are maintaining a disciplined approach to capital allocation and creating long term value for shareholders."

16:18 EDT MGM Resorts reports Q1 consolidated Adjusted EBITDA increased 5% to $740M - Compared to $701M in the prior year quarter.

16:15 EDT Texas Roadhouse reports Q1 comparable restaurant sales increase of 5.2% - Texas Roadhouse reported that comparable restaurant sales increased 5.2% at company restaurants and 4.3% at domestic franchise restaurants in Q1.

16:12 EDT Century Aluminum appoints Jesse Gary COO - Century Aluminum Company announced that its board has elected Jesse Gary as the company's COO, a newly created position. Gary will continue to serve as Century's General Counsel, and Morgan Walbridge has been promoted to Deputy General Counsel and will oversee the legal department on a day-to-day basis.

16:10 EDT IntriCon CFO Scott Longval appointed COO - Scott Longval, who has served as IntriCon's CFO since July 2006, will assume the newly created role of COO, effective immediately. In his additional role as COO, Longval will initially assume responsibility for the day-to-day leadership and management of operations, including manufacturing, quality control, product delivery, human resources and general administration.

16:09 EDT Ring Energy sees FY19 capex around $154M - Ring Energ announced a preliminary capital expenditure budget for 2019 of approximately $154M. The preliminary budget includes the estimated cost to drill 50 new horizontal wells and the total expenditures incurred in the first quarter of 2019 by both Ring and the Northwest Shelf assets acquired from Wishbone Energy Partners. With the recent addition of a second drilling rig, management stated that the majority of funds will be allocated to its Central Basin Platform and newly acquired NWS assets. Management estimates that the Company will drill and complete 50 new horizontal wells in 2019 - 28 new San Andres horizontal wells on its CBP asset, 21 new San Andres horizontal wells on its NWS asset, and one new Brushy Canyon horizontal well on its Delaware Basin property.

16:07 EDT G1 Therapeutics plans to request pre-NDA meeting for Trilaciclib - G1 Therapeutics provided a regulatory update on trilaciclib, a first-in-class myelopreservation agent designed to protect the bone marrow from damage by chemotherapy and improve patient outcomes. Based on written feedback from its end-of-Phase 2 meeting with the FDA and discussions with European regulatory authorities, the company plans to submit marketing applications in the U.S. and Europe for trilaciclib for myelopreservation in small cell lung cancer, or SCLC. These submissions will be based on currently available data from three randomized, double-blind, placebo-controlled SCLC clinical trials, as well as safety data collected across all completed and ongoing clinical trials. G1 will request a pre-New Drug Application, or NDA, meeting with the FDA and anticipates it will be scheduled later this year. The company plans to submit a Marketing Authorization Application, or MAA, to the European Medicines Agency, or EMA, subsequent to an NDA filing.

16:07 EDT Alphabet reports Q1 paid clicks on Google properties up 39% year-over-year - Reports Q1 paid clicks on Google properties up 39% from the prior year and down (9)% from the prior quarter. Reports Q1 cost-per-click on Google properties down (19)% from the prior year and up 5% from the prior quarter. Reports Q1 impressions on Google Network Members' properties up 6% year-over-year and up 5% quarter-over-quarter. Reports Q1 cost-per-impression on Google Network Members' properties up 1% from the prior year and down (14)% from the prior quarter.

16:04 EDT Alphabet reports Q1 traffic acquisition cost $6.86B vs. $6.29B last year

16:02 EDT Americas Silver backs FY19 silver production guidance 1.6M-2M ounces - Guidance for 2019 remains unchanged at 1.6 - 2.0 million silver ounces and 6.6 - 7.0 million silver equivalent ounces at cash costs of $4.00 to $6.00 per silver ounce and AISC of $10.00 to $12.00 per silver ounce.

16:00 EDT G1 Therapeutics trading halted, news pending

15:17 EDT FAA says has not received Boeing's updated MCAS software to review - After AFP reported earlier, citing a source, that Boeing had submitted its proposed 737 MAX fix to the FAA, the FAA stated via its official Twitter account: "Correction: the #FAA has not received @Boeing's MCAS software enhancement for review." Reference Link

14:31 EDT Dwight Capital express interest in acquiring HomeStreet assets - Dwight Capital sent a letter to the board of directors of HomeStreet to "express our interest in acquiring a subset of HomeStreet's multifamily mortgage lending business, which would consist of the Fannie Mae DUS lending operations and related mortgage servicing rights, at a premium to its fair market value." "This letter itself does not constitute an offer and we seek to engage in limited and confirmatory due diligence prior to making a formal offer and executing a binding agreement," the letter reads. "In light of the significance of this letter to your shareholders and ours, as well as the potential for selective disclosures, our intention is to release the text of this letter to the public. Due to the importance of this proposal, we expect the Board to engage in a full dialogue. My leadership team and I would be happy to make ourselves available to meet with you and your Board at your earliest convenience. Depending on the nature of your response, Dwight reserves the right to pursue all necessary steps to ensure that HomeStreet, Inc.'s shareholders are provided with the opportunity to realize the value inherent in our proposal. We believe that our proposal represents a unique opportunity to create significant value for HomeStreet's shareholders and employees. We look forward to a prompt and favorable reply to engage in discussions."

14:13 EDT Walmart hints at response to Amazon one-day shipping plans in tweet - After Amazon (AMZN) announced during the company's earnings call on Thursday that it plans to spend $800M in the second quarter to move to one-day delivery for Prime customers, the official corporate Twitter account of Walmart (WMT) tweeted the following on Friday night: "One-day free shipping...without a membership fee. Now THAT would be groundbreaking. Stay tuned." Though the retailer made no mention of its e-commerce competitor, the assumption is that the tweet is in response to Amazon's news, and the associated slides in shares of Walmart and Target (TGT) on the day after Amazon's report. Reference Link

14:05 EDT Terra Flowers reports 5.08% passive stake in FTD Companies - In a regulatory filing, Terra Flowers disclosed a 5.08% stake in FTD Companies, which represents 1.44M shares. The filing does not allow for activism.

13:16 EDT Dell, Microsoft announce expansion of partnership agreement - Dell Technologies (DELL) and Microsoft (MSFT) announced they are expanding their partnership to "address a wider range of customer needs and help accelerate digital transformations." Through this collaboration, the companies will deliver a fully native, supported, and certified VMware cloud infrastructure on Microsoft Azure, the companies said. Additionally, joint Microsoft 365 and VMware Workspace ONE customers will be able to manage Office 365 across devices via cloud-based integration with Microsoft Intune and Azure Active Directory. VMware (VMW) will also extend the capabilities of Microsoft Windows Virtual Desktop leveraging VMware Horizon Cloud on Microsoft Azure. "At Microsoft, we're focused on empowering customers in their digital transformation journey, through partnerships that enable them to take advantage of the Microsoft cloud, using the technologies they already have," said Satya Nadella, CEO, Microsoft. "Together with Dell Technologies and VMware, we are providing our mutual customers with an integrated cloud experience and digital workplace solutions to open up new opportunities and meet their evolving needs."

12:52 EDT Archer Daniels CEO Luciano bought $1M worth of shares today - Archer Daniels Midland CEO Juan Ricardo Luciano disclosed the purchase of 23,657 shares today for a price of $42.30 or $1,000,691. Luciano now directly owns 569,152 shares of Archer Daniels. The company's CFO Ray Young also disclosed the purchase of 6,000 shares for a price of $42.76 or $256,542. Archer Daniels in afternoon trading is up $2.24 to $43.15.

12:36 EDT Banco Bilbao says 'sound' risk indicators kept in 'challenging' environment - BBVA CEO Onur Genc said when reporting earnings, "Despite a challenging macro economic environment, our diversified model allowed us to maintain sound risk indicators and a solid capital position...we continue to move forward in our transformation, with a clear impact on growth of our customer base, productivity, efficiency and user experience...Digital sales accounted for 57 percent of the total for the quarter. We maintain our goal of surpassing the 50-percent threshold of customers banking with us through their smartphones by year-end." Reference Link

12:22 EDT Banco Bilbao trading resumes

12:02 EDT Ramaco Resources appoints Jeremy Sussman as CFO - Ramaco Resources announced the appointment of Jeremy Sussman as CFO of the company, effective in early May. Randall Atkins, the company's Executive Chairman who has also been serving as the company's CFO since July 1, 2018, will step down as CFO effective upon Sussman's appointment. Atkins will continue to serve as the company's Executive Chairman. Most recently, Sussman served as Managing Director - Mining and Metals at Clarksons Platou Securities.

12:00 EDT Gardner Denver rises 15.8% - Gardner Denver is up 15.8%, or $4.43 to $32.48.

11:31 EDT Boeing CEO: We know there are improvements that can be made to MCAS - Boeing CEO Dennis Muilenburg is speaking at a press conference from the company's annual meeting.

11:29 EDT Boeing will ensure Max is 'safest airplane out there to fly,' CEO says - Boeing CEO Dennis Muilenburg is speaking at a press conference from the company's annual meeting.

11:24 EDT Boeing CEO says MCAS is not anti-stall system - Boeing CEO Dennis Muilenburg is speaking at a press conference from the company's annual meeting.

11:22 EDT Boeing 'deeply' regrets what happened in two Max accidents, CEO says - Boeing CEO Dennis Muilenburg is speaking at a press conference from the company's annual meeting.

11:21 EDT When asked if he considered resigning, Boeing CEO says 'focused on safety' - Boeing CEO Dennis Muilenburg is speaking at a press conference from the company's annual meeting.

11:20 EDT Delrahim tells CNBC that he hasn't made up mind on Sprint, T-Mobile merger - U.S. antitrust chief Makan Delrahim tells CNBC's David Faber that he has not made a decision on whether to approve the proposed merger between Sprint (S) and T-Mobile (TMUS). "I have not made up my mind," he said, adding that "The investigation continues. We've requested some data from the companies that will be forthcoming. We don't have a set number of meetings or a time line." Reference Link

11:19 EDT Boeing CEO says 'regret the impact' of the 737 Max - Boeing CEO Dennis Muilenburg is speaking at a press conference from the company's annual meeting.

11:01 EDT Goldman Sachs CEO: April has been 'more constructive' from macro perspective - Goldman Sachs Chairman and CEO David Solomon made the comments on the "more constructive" environment during an interview on CNBC.

10:35 EDT Ericsson, Ambra sign global contract to sell 5G-ready mining industry automation - Ericsson and Ambra Solutions have announced a global cooperation agreement to lead automation for the mining industry, the companies said. Ambra has selected Ericsson as a radio partner of choice to provide 5G-ready network solutions to automate ventilation systems, real-time personnel and vehicle tracking, and remote controlling of machinery like scoop diggers, hauler trucks, drillers, and other mining equipment.

10:10 EDT Teladoc Health says obtains accreditation in credentialing - Teladoc Health has obtained accreditation in credentialing, the company said on its website. Reference Link

10:00 EDT Accenture wins blanket purchase order agreement from DOE worth up to $2B - Accenture has been awarded a blanket purchase order agreement by the U.S. Department of Energy that blends core information technology services with ongoing and new modernization priorities for DOE technology systems and infrastructures. With a potential value of $2B and a five-year performance period, the CIO Business Operations Support Services contract covers general IT support, telecommunications, cybersecurity, systems architecture and engineering, and shared services. Under the terms of the CBOSS contract, Accenture Federal Services will support DOE's plan to migrate from an on-premises service model to a modern, cloud-based IT services model that will incorporate leading-edge, commercially available products and services. The approach aims to improve IT flexibility and reduce redundant infrastructure and commodity services while strengthening the overall security of the DOE's IT environment.

09:47 EDT National Presto Industries, Inc. falls -4.4% - National Presto Industries, Inc. is down -4.4%, or -$4.92 to $107.58.

09:47 EDT Veoneer falls -19.2% - Veoneer is down -19.2%, or -$5.13 to $21.61.

09:47 EDT Gardner Denver rises 14.7% - Gardner Denver is up 14.7%, or $4.11 to $32.16.

09:35 EDT Yext unveils new global headquarters in NYC, to hire 500 over next five years - Yext unveiled its new global headquarters on Manhattan's West Side, The Yext Building. As Yext grows around the world, the nine-floor building will allow the company to hire hundreds of employees in its home of New York City. Yext will redesign the interior of the building over the coming months, targeting March 2020 to move all New York City Yexters to the new space. Over 12 years, Yext's investment in the building is expected to top $150M, which includes rent and tens of millions for build-out. The company's planned creation of 500 new jobs over the next five is supported by up to $6M in performance-based Excelsior Tax Credits from New York State over ten years.

09:22 EDT Allergan, Editas Medicine present initial data on LCA10 natural history study - Allergan (AGN) and Editas Medicine (EDIT) announced initial data from the ongoing natural history study to evaluate patients with Leber congenital amaurosis 10, or LCA10, a rare form of blindness caused by mutations in the CEP290 gene. The companies reported these data in an oral presentation at the Retinal Cell and Gene Therapy, or RCGT. The companies initiated the natural history study to prospectively evaluate and confirm the course of disease in patients and determine the reproducibility and stability of ophthalmic assessments over time. This knowledge has informed the planned Phase 1/2 interventional clinical trial design for AGN-151587, or EDIT-101, an experimental CRISPR genome editing medicine being investigated for the treatment of LCA10. Massachusetts Eye and Ear, an international center for treatment and research and a teaching hospital of Harvard Medical School, is one of seven sites enrolling patients in this natural history study.

09:20 EDT PTC Therapeutics' Translarna approved in Brazil for muscular dystrophy - PTC Therapeutics announced that Translarna - ataluren - has been granted marketing approval from the Brazilian National Health Surveillance Agency under rare diseases procedure, for the treatment of ambulatory children five years and older with Duchenne muscular dystrophy caused by a nonsense mutation. Patients now can have access to a treatment that targets the underlying cause. Duchenne muscular dystrophy is a rare, irreversible, and fatal genetic disorder that results in progressive muscle weakness from early childhood and leads to premature death in the mid-twenties due to heart and respiratory failure.

09:15 EDT Planet Green Holdings regains compliance with NYSE American - Planet Green Holdings announced on Friday, April 26, the NYSE American notified Planet Green that the company had regained compliance with the NYSE American listing requirements because the company has resolved the continued listing deficiency with respect to Section 1003(a)(i) and Section 1003(a)(ii) of the NYSE American Company Guide.

09:06 EDT GoPro's YouTube channel reaches 2 billion views - GoPro's YouTube channel has surpassed two billion views, and the YouTube community has spent more than four billion minutes watching the content GoPro has shared. In celebration, GoPro has released 'GoPro: 2 Billion Views with YOU' on YouTube. The video includes a collection of GoPro's YouTube highlights.

09:05 EDT DHI Group names Chris Henderson as Chief Strategy Officer - DHI Group announced it has hired Chris Henderson as its new Chief Strategy Officer. Based in Denver, Henderson will oversee the development of strategic priorities and implementation of specific cross functional initiatives for the company overall and for its three services: Dice, eFinancialCareers and ClearanceJobs. Henderson will join DHI's executive team and report directly to CEO Art Zeile

09:03 EDT Fly Intel: Pre-market Movers - HIGHER: AMC Theaters (AMC), up 4% after confirming it set a new single-day U.S. attendance record on Saturday amid the record-breaking opening of Disney's (DIS) "Avengers: Endgame". Disney shares are up about 2% in pre-market trading... Gardner Denver (GDI), up 13% after Wall Street Journal reported the company is closing in on a deal to combine with a division of Ingersoll-Rand (IR) to form the world's second-largest manufacturer of industrial pumps and compressors. Ingersoll-Rand shares are up 4% following the report. UP AFTER EARNINGS: Spotify (SPOT), up 5%... Loews (L), up 3%... McDermott (MDR), up 3%. DOWN AFTER EARNINGS: Restaurant Brands (QSR), down 4%... Veoneer (VNE), down 17%. ALSO LOWER: Occidental (OXY), down 2% after Anadarko Petroleum (APC) announced that it intends to resume negotiations with the company after its offer to acquire Anadarko.... Momo (MOMO), down 7% after announcing that certain mobile app stores in China have removed its Tantan mobile app on direction of governmental authorities in China... Boeing (BA), down about 1% after a Wall Street Journal report said the planemaker did not tell Southwest Airlines (LUV), the largest MAX customer, when the airline began flying 737 MAX jets in 2017 that a standard safety feature, found on earlier models and designed to warn pilots about malfunctioning sensors, had been deactivated.

09:03 EDT SAP, Uber Freight announce partnership to modernize the freight industry - SAP and Uber Freight announced a partnership to modernize the freight industry through intelligent process automation and better access to a network of connected and reliable drivers. The integration of Uber Freight into SAP Logistics Business Network will let customers access transportation rates from Uber's digitally activated carrier network and gain real-time quotes and guaranteed freight capacity, greatly simplifying load management and execution.

08:43 EDT Precipio announces services contract with healthcare management group in Egypt - Precipio announced that it has signed a services contract with a health care management group serving several major hospitals based in Cairo, Egypt. Precipio is engaged to provide both pathology diagnostic services as well as access to proprietary technologies developed by Precipio. Initially, the contract calls for sending patient biopsies for primary diagnosis and secondary opinion. Follow-on intended business collaborations will include the establishment of laboratory operations within Egypt that will license Precipio's proprietary technologies to provide liquid biopsy testing using ICE-COLD PCR technology, and HemeScreen for hematologic molecular testing.

08:34 EDT ElectraMeccanica granted battery cartridge design patent in China - Electra Meccanica has been awarded a patent in China by the National Intellectual Property Administration for the design of its proprietary battery cartridge. The patent is valid for 10 years from the filing date and covers Electra Meccanica's proprietary battery cartridge design that is a feature underlying the company's SOLO EV. The patent in China expands upon previous successful battery cartridge patent registrations in Europe, Japan and Canada.

08:16 EDT LogicBio Therapeutics granted orphan drug designation for LB-001 by FDA - LogicBio Therapeutics announced that the FDA has granted orphan drug designation to LB-001, a recombinant adeno-associated viral vector with human methylmalonyl-COA mutase gene for the treatment of methylmalonic acidemia.

08:16 EDT Roan forms committee after 'multiple unsolicited indications of interest' - Roan Resources announced that it has received multiple unsolicited indications of interest to purchase the company. In addition, the company has also received indications of interest for in-basin consolidation opportunities. In response to the unsolicited indications of interests, the company has formed a transactional working committee of its Board to evaluate a potential sale or merger of the company. The compeany said, "The Committee is considering all potential merger and acquisition opportunities to assist the Board in maximizing shareholder value and will act in the best interest of all its shareholders. In order to assist the Committee in evaluating any potential sale or merger of the Company, it will mandate an investment bank in the near future. While the Committee continues to evaluate all potential value maximizing transactions, the Company remains committed to creating maximum value on a stand-alone basis and to obtaining operational excellence across its premier asset base in the core of the Anadarko Basin. Given the size of the Company's undeveloped acreage position in the core of the play, Roan is optimally and uniquely positioned in the basin to have the flexibility to achieve optimal scale by growing its asset base organically or through value maximizing strategic alternatives."

08:11 EDT Lakeland Bancorp increases quarterly dividend 9% to 12.5c per share - Dividend to be paid on May 17 to shareholders of record as of May 9.

08:07 EDT Guess enters into $170M accelerated share repurchase program - On April 26, using $170M of the net proceeds from its Convertible Senior Notes offering, Guess entered into an accelerated share repurchase program, or ASR, for the company's shares with JPMorgan Chase Bank. "Initial delivery of shares, which is scheduled to occur on April 29, will represent approximately 60% of the total shares that are expected to be repurchased under the ASR, which is scheduled to be completed by the end of the third quarter of 2019. The purchase price per share of the common stock repurchased through the ASR will generally be equal to the average volume-weighted average price of the company's shares during the term of the ASR, less an agreed discount." The exact number of shares repurchased pursuant to the ASR will be determined based on such purchase price.

08:05 EDT NIC Inc. appoints Brian Anderson as Chief Technology Officer - NIC Inc. has hired Brian Anderson as the company's Chief Technology Officer. He will report to the CEO and serve as a member of NIC's Senior Leadership team. Prior to joining NIC, Anderson served as the Chief Technology Officer of Lexmark.

08:04 EDT Bayer, Orion say FDA grants priority review for darolutamide - Orion Corporation and Bayer (BAYRY) announced that the U.S. Food and Drug Administration has accepted the New Drug Application for review and granted Priority Review for darolutamide for the treatment of non-metastatic castration-resistant prostate cancer in the U.S. The NDA and Priority Review status were based on data from the Phase III ARAMIS trial in men with nmCRPC. Darolutamide is an investigational, non-steroidal androgen receptor antagonist with a distinct chemical structure that binds with high affinity to the receptor, inhibiting the growth of prostate cancer cells. The FDA grants Priority Review for the applications of medicines that, if approved, would provide significant improvements in the safety or effectiveness of the treatment, diagnosis, or prevention of serious conditions when compared to standard applications. Bayer recently submitted an application to the European Medicines Agency and the Ministry of Health, Labor and Welfare in Japan. Bayer is also in discussions with other health authorities regarding submissions. Darolutamide is being developed jointly by Orion Corporation and Bayer.

07:53 EDT OneSmart authorizes $50M share repurchase program - OneSmart has authorized a share repurchase program to repurchase up to $50.0M worth of its shares over the next 12 months, subject to market conditions. The company plans to fund repurchases from its existing cash balance or future cash generated by operating and financing activities. As of November 30, the company had cash and cash equivalents of $111.5M and short-term investments of $107.6M.

07:45 EDT Innovate Biopharmaceuticals larazotide shows improvements in NASH biomarkers - Innovate Biopharmaceuticals announced that larazotide acetate, a new class of medicine based on gut-restricted peptides which re-normalize the intestinal epithelial barrier and gut-liver axis, is the first drug with this mechanism to show improvements in NASH biomarkers and endpoints. Key topline findings from a biopsy-proven translational mouse model of NASH will be presented at an analyst meeting at the Digestive Disease Week, or DDW, conference as well submitted to The Liver Meeting of the American Association for the Study of Liver Diseases, or AASLD. Active patient recruitment efforts are underway and more than 100 clinical research sites have been selected to participate in the registration trial. In a 12 week preclinical study of larazotide acetate combined with obeticholic acid, or OCA, data demonstrated statistically significant reductions in plasma total cholesterol, absolute and relative liver weights, relative and total liver cholesterol and relative and absolute liver triglycerides, when compared to vehicle control animals that did not receive any larazotide or OCA. The non-alcoholic fatty liver disease activity score, the clinical measure of NASH activity, improved in the majority of animals treated with the combination of larazotide/OCA when compared to vehicle. Histological steatosis scores trended positively, and lobular inflammation was statistically significantly improved in the larazotide/OCA group when compared to vehicle control animals.

07:39 EDT Biogen announces nomination of Catalent CEO John Chiminski to board of directors - Biogen (BIIB) announced the nomination of John Chiminski, William Hawkins and Jesus Mantas to stand for election to the company's board at its annual meeting of stockholders, scheduled for June 19. Chiminski is chair of the board and CEO of Catalent (CTLT). Hawkins is a senior advisor to EW Healthcare Partners. Mantas is the managing partner and GM leading worldwide strategy for IBM (IBM) Global Business Services. Chiminski, Hawkins and Mantas are being nominated at the annual meeting of stockholders along with the existing 11 directors, who will stand for re-election. If all nominees are elected, the board would expand to 14 directors, 13 of whom would be independent.

07:35 EDT Imax reports opening box office record for Marvel Studios' Avengers: Endgame - IMAX announced that Marvel Studios' Avengers: Endgame, which marks the second Hollywood film to ever be shot entirely with IMAX cameras, set a new IMAX all-time worldwide opening weekend record grossing approximately $91.5M, surpassing the previous record holder Star Wars: The Force Awakens by 92%. Endgame was filmed entirely using IMAX cameras.

07:33 EDT Gridsum partners with ShineWing for AI and big data in professional services - Gridsum has entered into a strategic alliance with ShineWing, the largest domestic accounting and consulting firm in China, to intelligentize professional services. Gridsum and ShineWing will work together to promote the application of big data and AI within professional services. Gridsum will leverage its experience in developing emerging AI, and big data analytic technologies and apply them to ShineWing's professional services practice in auditing, assurance, management consulting, construction consulting, and taxation and accounting. In addition, Gridsum and ShineWing will jointly develop an innovative Platform as a Service, which will provide a one-stop platform for intelligentized professional services to companies across a variety of industries.

07:23 EDT Canopy Growth provides update on New York industrial park - Canopy Growth has secured a 308,000 sq. ft. facility on a 48-acre property in Kirkwood, NY for establishing its Hemp Industrial Park in the Southern Tier region of New York State. Construction will commence this summer. The vision for the property is to build the infrastructure necessary to support hemp-derived cannabinoid extraction and related manufacturing together with providing an opportunity for participation by other businesses in the hemp industry. The company will begin hiring senior leadership in late 2019 and recruit the full workforce in mid 2020. Canopy Growth has also begun securing farm capacity to supply enough hemp for its own future extraction and formulation activities within the park. It is anticipated that the operations will create hundreds of new local full-time positions. The company will begin approaching third-party organizations to join the ecosystem.

07:18 EDT Mack-Cali Realty issues letter to stockholders on Bow Street proposal, nominees - Mack-Cali Realty mailed a letter to stockholders before its Annual Meeting of Stockholders, scheduled for June 12, stating that the unsolicited proposal from Bow Street Special Opportunities Fund and David Werner Real Estate Investments to acquire the company's suburban and waterfront office assets is "grossly inadequate, illusory, unworkable and not in the best interest of the company or its stockholders". The Mack-Cali Board has unanimously rejected the Proposal. In response, Bow Street has launched a proxy contest seeking Board representation, in the Board's view, "to force an immediate fire sale of these premium assets or the entire company, to the detriment of all other Mack-Cali stockholders". Mack-Cali recommends that stockholders vote on the white proxy card "for" all of Mack-Cali's 11 nominees.

07:16 EDT Miragen Therapeutics to present new remlarsen data at ARVO - Miragen Therapeutics announced data from a preclinical study of remlarsen, a microRNA-29 replacement, exploring the anti-fibrotic effects of remlarsen in the cornea of rats after corneal ulceration. The data will be delivered in a poster presented at the Association for Research in Vision and Ophthalmology, or ARVO. Remlarsen was administered topically to the rat cornea for up to 28 days following an induced chemical burn. Eyes were scored for corneal haze, then evaluated histologically for corneal thickness and expression of a-SMA, or alpha smooth muscle actin, a marker of epithelial-to-mesenchymal transition and fibroblast-to-myofibroblast transition. Expression of collagen and other fibrosis-associated genes was assessed using quantitative reverse transcription-polymerase chain reaction. Remlarsen treatment accelerated the healing of corneal injury, resulting in a more rapid restoration of epithelial thickness and a reduction in stromal thickness as compared to saline-treated injured eyes. Remlarsen treatment appeared to reduce the expression of multiple collagens and fibrosis-associated genes from seven to 14 days post-injury and to reduce a -SMA protein expression in the epithelium and stroma at 14 days. Remlarsen treatment appeared to reduce corneal hazing and scarring beginning at 10 days post-burn. Dose and treatment schedule were optimized in preparation for enabling toxicology studies to support human clinical trials.

07:13 EDT Wynn Resorts board's proposals recommended by ISS and Glass Lewis - Wynn Resorts announced that independent proxy advisory firms, Institutional Shareholder Services, or ISS, and Glass Lewis, have recommended that the company's shareholders vote for all of the Wynn Resorts Board's proposals at the company's 2019 Annual Meeting of Shareholders to be held on May 7. Both ISS and Glass Lewis also recommend that shareholders vote "for" all three directors who are up for re-election. In supporting Wynn Resorts' director nominees, Glass Lewis stated among other things: "Given the very high level of refreshment of the Company's management and board, as well as the remedial actions taken by the company following Mr. Wynn's ouster, we do not believe it is necessary for shareholders to oppose the election of any of the board's current directors (...) In supporting Wynn Resorts' executive compensation, ISS stated: "The company has made a number of changes to its executive pay practices in 2018 and 2019 that are expected to strengthen the alignment of pay and performance."

07:09 EDT Moleculin Biotech advances with patient recruitment in Phase 1/2 Annamycin trial - Moleculin is augmenting US clinical trials with trials in Poland, speeding the process of patient recruitment and data collection. The company recently recruited 3 patients in 6 weeks in Poland, whereas in the U.S. it took a full year to build a similar, complete cohort. The company now has 2 clinical trials with patients enrolled in Poland. The phase 1/2 clinical trial now underway in Poland for the company's Annamycin compound has shown "promising" results with one trial patient's acute myeloid leukemia now in remission, making the patient eligible for a bone marrow transplant. While significant additional study is necessary to definitively demonstrate causality, Moleculin has already begun to identify more patients in Poland for the next cohort of the same trial and 2 more patients for its WP1220 topical treatment of cutaneous T-cell lymphoma. The additional patient safety data gained from the Polish trials may also assist in the FDA's review of cardiac safety which can be a key factor in regulatory approval.

07:07 EDT Ritchie Bros., Gordon Brothers to sell assets of Welded Construction - Ritchie Bros. announced that it has received bankruptcy court approval to purchase the assets of Welded Construction, L.P. together with Gordon Brothers. The two companies will work together to sell the Welded Construction assets through multiple selling channels.

07:05 EDT Anadarko to resume negotiations with Occidental Petroleum - Anadarko Petroleum (APC) announced that it intends to resume negotiations with Occidental Petroleum (OXY) in response to Occidental's proposal to acquire Anadarko, which was announced by Occidental on April 24, 2019. Anadarko is resuming its earlier negotiations with Occidental because Anadarko's board of directors has unanimously determined that the Occidental Proposal could reasonably be expected to result in a "Superior Proposal". The Occidental Proposal reflects "significant improvement with respect to indicative value, terms and conditions, and closing certainty as compared to any previous proposal." Under the Occidental Proposal, Occidental would acquire Anadarko in a transaction with consideration comprised of $38.00 in cash and 0.6094 of a share of Occidental common stock per share of Anadarko common stock. Under the Chevron Merger Agreement, Chevron (CVX) would acquire Anadarko in a transaction with consideration comprised of $16.25 in cash and 0.3869 of a share of Chevron common stock per share of Anadarko common stock. The Anadarko board's determination allows Anadarko to resume negotiations with Occidental in accordance with the Chevron Merger Agreement. The Chevron Merger Agreement remains in effect and accordingly the Anadarko board reaffirms its existing recommendation of the transaction with Chevron at this time.

07:04 EDT AMC Theatres set new single-day U.S. attendance record on Saturday - AMC Theatres announced setting new records for its theatres in the United States. AMC confirmed that it set a new single-day U.S. attendance record on Saturday, as well as twice setting new single-day Food & Beverage revenue records in the U.S., doing so back-to-back on Friday and again on Saturday. With AVENGERS: ENDGAME on its way to demolishing the previous opening-weekend domestic industry box office record, it also helped fuel an all-time single day attendance record at AMC on Saturday with more than 2.6 million tickets sold. This easily outpaced the previous single-day U.S. attendance record for AMC set during the opening weekend of BLACK PANTHER, just fourteen months earlier in 2018. AMC started the weekend on Friday with a new single-day U.S. F&B revenue record of more than $13M. That record lasted all of one night, before it was shattered again on Saturday, with more than $15M sold. AMC doubled its previous record for single-day mobile F&B pre-orders, through the mobile app and website. A record-number 19 AMC locations were open continuously around-the-clock this weekend from Thursday morning through Sunday night. The 63,000 AVENGERS: ENDGAME showtimes this weekend is 16,000 more than the previous record for a single movie on opening weekend. AMC also put a weekend-record nearly 11 million tickets on sale from Thursday through Sunday for AVENGERS: ENDGAME. Demand for AVENGERS: ENDGAME was so strong that AMC added more than 5,000 last minute showtimes this weekend, above and beyond its already ambitious and record setting plan announced on Friday morning.

06:49 EDT Merck and AstraZeneca's Lynparza granted positive EU opinion in ovarian cancer - AstraZeneca (AZN) and Merck (MRK) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion, recommending Lynparza as a first-line maintenance treatment in BRCA-mutated advanced ovarian cancer. The CHMP's recommendation is for the use of Lynparza as monotherapy for the maintenance treatment of adult patients with advanced - FIGO stages III and IV - BRCA1/2-mutated high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response following completion of first-line platinum-based chemotherapy. The EMA committee's positive opinion is based on data from the Phase 3 SOLO-1 trial which showed that Lynparza reduced the risk of disease progression or death by 70% versus placebo following response to platinum-based chemotherapy. Lynparza is currently approved in over 64 countries, including those in the EU, for the maintenance treatment of platinum-sensitive relapsed ovarian cancer regardless of BRCA status. It is approved in the U.S. as first-line maintenance treatment in BRCAm advanced ovarian cancer following response to platinum-based chemotherapy. Regulatory reviews are underway in other jurisdictions for both ovarian cancer and breast cancer.

06:33 EDT Immunic appoints Tamara Seymour as Interim CFO - Immunic announced the appointment of Tamara Seymour, MBA, as its Interim CFO, effective April 26. Since 2018, Seymour has served as a financial advisor, assisting life sciences companies with merger and acquisition activities and other finance-related needs.

06:14 EDT JAB reports preliminary results of tender offer for 150M of Coty shares - JAB announced the preliminary results of the previously announced tender offer by its affiliate for 150M additional shares of Coty Class A common stock at a price of $11.65 per share in cash. The tender offer expired at 5:00 p.m., New York City time, on April 26, and was not extended. All conditions having been satisfied or waived as of expiration of the tender offer, JAB's affiliate intends to, pending final proration as described further below, accept for payment 150M shares validly tendered pursuant to the tender offer and not properly withdrawn or otherwise delivered pursuant to a Notice of Guaranteed Delivery. Based on the preliminary tabulation by Computershare Trust Company, N.A., the depositary for the tender offer, a total of 216,929,200 Shares were validly tendered pursuant to the tender offer and not properly withdrawn. In addition, the depositary has advised that Notices of Guaranteed Delivery have been delivered for 144,164,361 Shares. Because the tender offer was oversubscribed, the number of Shares that JAB's affiliate will purchase from each tendering stockholder will be prorated to limit the aggregate purchase to 150M Shares. Based on the preliminary information provided by the depositary, and including all Shares tendered by Notice of Guaranteed Delivery, JAB estimates that the proration factor for the tender offer will be approximately 41.54%.

06:09 EDT MoviePass competitor Sinemia abruptly closes down - MoviePass competitor Sinemia announced on its website that it is closing its discounted movie ticket subscription service operations in the U.S. immediately. "Today, with a heavy heart, we're announcing that Sinemia is closing its doors and ending operations in the US effective immediately," said a message posted on the company's website. "We are all witnessing that the future of moviegoing is evolving through movie ticket subscriptions," said Sinemia's statement. "However, we didn't see a path to sustainability as an independent movie ticket subscription service in the face of competition from movie theaters as they build their own subscriptions." Reference Link

06:08 EDT United Therapeutics announces FDA approval of XPS, Steen Solution - United Therapeutics announced that its collaborator, XVIVO Perfusion, a subsidiary of XVIVO Perfusion AB, has received Premarket Approval, or PMA, from the FDA for the products XPS and STEEN Solution. This approval means that STEEN Solution, XPS and the accompanying single-use articles are the only medical device products that are approved in the United States for ex-vivo lung perfusion of initially unacceptable donated lungs at body temperature.

06:06 EDT Spotify reports Premium Subscribers grew to 100M, up 32% Y/Y - The company said, "Premium Subscribers grew to 100 million, up 32% Y/Y, reaching the high end of our guidance range of 97-100 million, and marking an important milestone in Company history. Outperformance was driven by a better than plan promotion in the US and Canada and continued strong growth in Family Plan. We also saw strong growth from the expansion of our Google Home Mini promotion, as well as the price reduction to our Spotify Premium + Hulu offering in the US. In March, we extended our partnership with Google by expanding our Google Home Mini promotion to two new markets, the UK and France. The new promotional offer is substantially similar to the deal offered in the US in Q4. In the UK and France, new and existing Family Plan master account holders can claim a free Google Home Mini voice speaker. We believe that voice speakers are a critical area of growth, particularly for music and podcasts, and we intend to continue to pursue opportunities to expand our presence in that area. We announced a significant step forward in our ongoing partnership with Samsung during Q1 whereby the Spotify app will be preloaded on millions of new devices globally. New users in the US who purchase Samsung's flagship Galaxy S10 device with the Spotify app preloaded also will have access to a special six month free trial offer for Spotify Premium. Additionally, we expanded our partnership with Hulu during Q1 by offering their limited commercial plan to our Standard $9.99 subscribers at no additional charge. This promotion replaces our existing $12.99 Spotify + Hulu bundle and builds upon the success and popularity of our Spotify Student + Hulu plan available in the US. Family and Student plans continue their fast growth and have continued to increase as a percentage of our total subscribers. Churn was flat with Q4 and also roughly the same as Q1 of 2018."

06:04 EDT Momo: Tantan mobile app removed from certain app stores by government direction - Momo announced that it has become aware that certain mobile app stores in China have removed the Tantan mobile app on direction of governmental authorities in China. The company is proactively communicating with the relevant government authorities and intends to fully cooperate with such authorities in order to restore the availability of the Tantan mobile app in the subject mobile app stores as soon as possible. The company also plans to conduct a comprehensive internal review of the content in the Tantan mobile app and undertake other measures necessary to stay in full compliance with all relevant laws and regulations. Pending restoration of the Tantan app in the relevant app stores in China, the company's ability to attract new Tantan users will be adversely affected, while existing Tantan users may continue to use the app.

05:45 EDT ICL announces issuance of final ruling in royalties arbitration - ICL announced that a final ruling was rendered yesterday in the arbitration proceeding held between Dead Sea Works, or DSW, and the State of Israel regarding the royalties payable to the State by DSW, bringing the arbitration proceedings between the parties that commenced in 2011 to an end. The final arbitration ruling was rendered following a joint notice submitted to the arbitrators by the parties pertaining to final agreements reached between the parties relating both to past periods, and to the mechanism to simplify the calculations of royalties to the State relating to the period as of January 1, 2018 and onward. Following the finalization of the arbitration, the company will book an additional provision of $11M, after tax, in its financial reports for Q1. The total royalties' payments made by the company to the State of Israel for the years 2000-2017 amount to approximately $1.3B.

05:27 EDT ObsEva reports further infant follow-up data from IMPLANT2 trial - ObsEva announced additional neonatal and infant follow-up results from the IMPLANT2 Phase 3 trial of its oral, oxytocin receptor antagonist, nolasiban, in patients undergoing IVF procedures. These additional data, resulting from additional follow-up extending to 6 months beyond delivery for the neonates and infants, are consistent with the favorable safety profile of nolasiban observed during pregnancy and within the first month following birth. Previously reported data from the IMPLANT2 trial showed a live birth rate, or LBR, of 34.8% and 27.7% in the nolasiban and placebo groups, respectively, a relative 25% increase. In the subgroup of patients receiving a single embryo transfer, or SET, on Day 5, LBR was 44.8% and 33.2% in the nolasiban and placebo groups, respectively, a relative 35% increase. There were 108 deliveries resulting in 109 infants in the placebo group and 131 deliveries resulting in 136 infants in the nolasiban group. Safety follow-up in the IMPLANT2 trial included neonatal outcomes assessed up to 28 days following birth, and infant development assessed using the Ages and Stages Questionnaires-3, or ASQ-3, completed 6 months following birth. Reported maternal, obstetrical, and neonatal outcomes up to 28 days post-delivery were very similar between the nolasiban and placebo groups. These measures included incidence and type of congenital malformations, as well as the incidence of intrauterine growth restriction. At 6-months post birth, infant follow-up and developmental outcomes showed no notable differences between the nolasiban and placebo groups in terms of ASQ-3 domain score, total score, or percentage of infants with at least one domain score below the respective cut-off value. Overall, Phase 3 IMPLANT2 trial results demonstrated that nolasiban increased rates of ongoing pregnancy and live birth following SET, with no safety concerns identified in either mothers or infants.

05:23 EDT Genentech: Part 1 of pivotal FIREFISH study risdiplam data - Genentech, a member of the Roche Group, announced today that new data for its approved and investigational medicines for the treatment of neurological conditions will be presented at the 71st American Academy of Neurology, or AAN, Annual Meeting from May 4-10 in Philadelphia, PA. Presentations include data from a pivotal study for risdiplam in spinal muscular atrophy, which has the potential to become the first oral treatment for this community. New research for OCREVUS in relapsing and primary progressive multiple sclerosis shows that its effect on reducing the risk of disability progression is associated with higher exposure and lower B-cell levels. Additional OCREVUS data demonstrate the importance of earlier treatment. New data for investigational medicines in neuromyelitis optica spectrum disorder, Huntington's disease, Alzheimer's disease and Duchenne muscular dystrophy will also be shared. Risdiplam data from Part 1 of pivotal FIREFISH study show infants with Type 1 spinal muscular atrophy achieve key motor milestones and improved survival after one year of treatment. New analyses in relapsing and primary progressive multiple sclerosis suggest that higher OCREVUS exposure and lower B-cell levels are important for control of disability progression. Satralizumab significantly reduces the risk of relapse in neuromyelitis optica spectrum disorder in pivotal SAkuraSky study. New data in Huntington's disease support dose selection for Phase III trial and provide insight on mutant huntingtin protein reduction.